Go with the Flow (Experts): How LabConnect’s FSP Team Accelerates Clinical Trials with Flow Cytometry Expertise
Clinical trial complexity continues to grow, especially when it comes to biomarker studies and the early phases of research. The need for specialized assays to measure specific biomarkers is critical, as these early indicators of efficacy and safety can guide the following trial phases.
However, the development and validation of these assays often require collaboration with multiple specialty lab vendors, each bringing unique expertise to the table. Coordinating study setup, sample logistics, and timely result delivery are key to reaching study milestones and progressing to the next phase.
These challenges are further amplified when it comes to global studies. Ensuring that specialty labs with the required capabilities are available in all regions, navigating international sample shipping logistics, and aligning timelines across multiple time zones can significantly impact the success of a clinical trial. In Phase I trials, where the margin for error is slim and the stakes are high, effectively managing these complexities can ensure the trial stays on track.
Accelerating Trials with the Right Technical and Scientific Resources
Sponsors and CROs are under pressure to conduct early-phase trials as efficiently as possible, especially when moving through the dose escalation and dose expansion phases. LabConnect’s Functional Service Provider (FSP) model is designed to meet these needs head-on. By providing dedicated full-time employees who are subject matter experts in their fields, LabConnect ensures that sponsors have the support they need in every phase of their trial. These project managers are not only knowledgeable in study setup, assay development, and validation but are also adept at troubleshooting and maintaining assays once they are deployed for sample analysis.
One of the standout features of LabConnect’s FSP model is its ability to offer unparalleled flexibility and scalability. Whether the sponsor requires expertise in biomarker and bioanalytical analysis, neutralizing antibody (nAb), potency, or sample management, LabConnect’s FSP teams are ready to scale rapidly to meet increasing demands. Additionally, collaboration between FSP teams ensures that expertise is shared, and sponsor needs are met efficiently.
Global Expertise in Action: Flow Cytometry
Flow cytometry is a critical component of many clinical trials. This technology enables the detailed analysis of cellular properties, providing insights into the biological activity of investigational therapies.
LabConnect’s strategic partnerships with a network of preferred specialty lab vendors ensure that flow cytometry analysis is handled with precision. These partnerships are built on a foundation of scientific rigor, expertise in developing and validating custom assays, availability of off the shelf validated assays, and a global footprint that ensures timely and comparable results.
The global footprint of these specialty labs ensures that even in multinational trials, flow cytometry can be performed consistently and efficiently, regardless of location. This collaboration allows LabConnect to remain agile when making data-driven decisions.
Supporting Faster, Informed Decisions
The ability to make these fast, informed decisions can be the difference between success and failure. LabConnect’s approach to data management, including the use of innovative tools like the SampleGISTICS™ digital pen, supports this need. The digital pen captures data in real time, tracking sample collections and identifying any missed collections or queries immediately.
This level of oversight reduces the risk of data discrepancies and accelerates the entire process. Every moment counts during a clinical trial. That’s why LabConnect’s FSP team is committed to precision, agility, and innovation, ensuring sponsors have the reliable, real-time data they need to confidently drive their trials.